Galapagos NV
GLPG
#4564
Rank
โ‚น190.19 B
Marketcap
โ‚น2,845
Share price
0.44%
Change (1 day)
25.19%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -โ‚น34.67

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -โ‚น30.50. In 2024 the company made an earnings per share (EPS) of โ‚น104.82 a decrease over its 2023 EPS that were of โ‚น319.14.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น34.67-133.07%
2024โ‚น104.82-67.16%
2023โ‚น319.14-199.64%
2022-โ‚น320.2899.03%
2021-โ‚น160.93-68.98%
2020-โ‚น518.80-298.06%
2019โ‚น261.94-554.64%
2018-โ‚น57.62-77.18%
2017-โ‚น252.51-326.21%
2016โ‚น111.63-134.19%
2015-โ‚น326.47-371.34%
2014โ‚น120.32-445.98%
2013-โ‚น34.7832.88%
2012-โ‚น26.17-82.07%
2011-โ‚น145.99-817.9%
2010โ‚น20.3412.73%
2009โ‚น18.04-120.79%
2008-โ‚น86.75-37.67%
2007-โ‚น139.1939.64%
2006-โ‚น99.6828.17%
2005-โ‚น77.776.25%
2004-โ‚น73.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
โ‚น272.95-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚น938.87-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น333.27-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚น121.58-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-โ‚น132.20 333.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น724.61-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น56.66-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚น323.40-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น682.95-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA